🟢 Indaptus Therapeutics is trading 5.81% up in pre-market with no clear catalyst identified

Indaptus Therapeutics is trading 5.81% up at $1.25 after no clear company-specific catalyst was identified for August 10, 2026.

• Its virtual annual meeting is scheduled for August 10, covering director elections, auditor ratification, and a new equity incentive plan; no separate announcement or meeting result was available before the pre-market move.
• Broader markets are only modestly mixed, so global sentiment does not clearly explain the gain.
• Volume and activity-level data were unavailable.